Dapagliflozin‐Associated Bullous Pemphigoid
- 8 November 2025
- journal article
- Published by Wiley in International Journal of Dermatology
- Vol. 65 (5) , 1078-1080
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Bullous Pemphigoid in a Patient with a Neuropsychological Disorder and a Possible Novel Drug Trigger: A Case Report and Review of the LiteratureSkin Health and Disease, 2022
- Association between sodium‐glucose co‐transporter 2 inhibitors and risk of bullous pemphigoid in patients with type 2 diabetes: a nationwide population‐based cohort studyJournal of the European Academy of Dermatology and Venereology, 2022
- GLP-1 Analogs and SGLT2 Inhibitors Do Not Increase Risk of Bullous PemphigoidJournal of Investigative Dermatology, 2021